BioCentury
ARTICLE | Clinical News

Acacia reports Phase II dry mouth data

October 15, 2013 11:15 PM UTC

Acacia Pharma Ltd. (Cambridge, U.K.) said APD515 given four times daily met the primary endpoint of reducing dry mouth symptoms at day seven vs. placebo in a 32-patient Phase II trial in advanced canc...